Relative risk (RR) of cancer in relation to occupational ELF-MF exposure; cancer sites with previous suggestion of an association with ELF-MF
| Men Exposure, μT | Women Exposure, μT | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Low <0.164 | Medium 0.164–0.250 | High 0.250–0.530 | Very high >0.530 | Low <0.164 | Medium 0.164–0.250 | High 0.250–0.530 | Very high >0.530 | |||||||
| Site, ICD7 | n | n | RR* (95% CI) | n | RR* (95% CI) | n | RR* (95% CI) | n | n | RR* (95% CI) | n | RR* (95% CI) | n | RR* (95% CI) |
| *Adjusted for age and socioeconomic status. | ||||||||||||||
| Colon, 153 | 139 | 285 | 0.8 (0.7 to 1.0) | 74 | 0.9 (0.6 to 1.1) | 46 | 0.7 (0.5 to 0.9) | 57 | 51 | 0.6 (0.4 to 1.0) | 38 | 1.1 (0.7 to 1.7) | 6 | 1.0 (0.4 to 2.3) |
| Liver and biliary passages, 155 | 29 | 88 | 1.3 (0.8 to 1.9) | 24 | 1.4 (0.8 to 2.4) | 22 | 1.6 (0.9 to 2.8) | 16 | 29 | 1.3 (0.7 to 2.4) | 12 | 1.2 (0.6 to 2.7) | 2 | 1.2 (0.3 to 5.3) |
| Liver, not specified as primary, 156 | 5 | 17 | 1.4 (0.5 to 3.7) | 6 | 1.8 (0.5 to 5.9) | 4 | 1.4 (0.4 to 5.4) | 1 | 2 | 1.5 (0.1 to 18.6) | 1 | 2.0 (0.1 to 35.7) | 1 | 11.2 (0.5 to 230.7) |
| Larynx, 161 | 18 | 54 | 1.2 (0.7 to 2.1) | 20 | 1.7 (0.9 to 3.3) | 7 | 0.7 (0.3 to 1.7) | 0 | 3 | 0 | 0 | |||
| Trachea, bronchus, lung, and pleura, 162 | 207 | 544 | 1.1 (0.9 to 1.2) | 135 | 1.0 (0.8 to 1.3) | 117 | 1.1 (0.9 to 1.4) | 52 | 89 | 1.3 (0.9 to 1.8) | 41 | 1.3 (0.9 to 2.1) | 5 | 0.9 (0.4 to 2.4) |
| Lung, not specified as primary, 163 | 3 | 9 | 1.1 (0.3 to 4.1) | 1 | 0.4 (0.0 to 4.3) | 6 | 3.0 (0.7 to 12.3) | 0 | 1 | 2 | 0 | |||
| Breast, 170 | 1 | 7 | 2.9 (0.4 to 23.4) | 2 | 3.1 (0.3 to 34.2) | 2 | 3.8 (0.3 to 43.5) | 402 | 492 | 1.0 (0.9 to 1.2) | 221 | 1.1 (0.9 to 1.3) | 37 | 1.1 (0.8 to 1.5) |
| Corpus uteri, 172 | 53 | 85 | 1.2 (0.8 to 1.7) | 42 | 1.4 (0.9 to 2.2) | 6 | 1.2 (0.5 to 2.7) | |||||||
| Testis, 178 | 51 | 181 | 1.2 (0.9 to 1.7) | 38 | 1.0 (0.6 to 1.5) | 23 | 0.7 (0.4 to 1.1) | |||||||
| Kidney, 180 | 81 | 207 | 1.0 (0.8 to 1.3) | 56 | 1.1 (0.8 to 1.5) | 62 | 1.4 (1.0 to 2.0) | 29 | 29 | 0.6 (0.4 to 1.1) | 15 | 0.7 (0.4 to 1.4) | 4 | 1.1 (0.4 to 3.1) |
| Urinary organs (excl. kidney), 181 | 118 | 367 | 1.3 (1.0 to 1.5) | 78 | 1.1 (0.8 to 1.4) | 46 | 0.8 (0.6 to 1.1) | 23 | 27 | 0.9 (0.5 to 1.7) | 13 | 1.1 (0.5 to 2.2) | 2 | 1.0 (0.2 to 4.3) |
| Malignant melanoma of skin, 190 | 117 | 274 | 0.9 (0.7 to 1.1) | 92 | 1.2 (0.9 to 1.6) | 37 | 0.7 (0.5 to 1.0) | 73 | 70 | 0.8 (0.6 to 1.1) | 26 | 0.8 (0.5 to 1.2) | 2 | 0.3 (0.1 to 1.3) |
| Skin (melanoma excl.), 191 | 49 | 134 | 1.1 (0.8 to 1.6) | 38 | 1.3 (0.9 to 2.0) | 22 | 1.0 (0.6 to 1.6) | 16 | 21 | 1.1 (0.5 to 2.1) | 6 | 0.7 (0.3 to 2.0) | 3 | 2.3 (0.6 to 8.2) |
| Pituitary, 195.3 | 8 | 31 | 1.4 (0.6 to 3.0) | 9 | 1.6 (0.6 to 4.2) | 11 | 2.4 (0.9 to 6.2) | 7 | 7 | 0.7 (0.2 to 2.0) | 7 | 1.6 (0.5 to 4.8) | 0 | |